UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hypoxia-Associated Factor, a Novel E3-Ubiquitin Ligase, Binds and Ubiquitinates Hypoxia-Inducible Factor 1α, Leading to Its Oxygen-Independent Degradation

Molecular and Cellular Biology, 2008-12, Vol.28 (23), p.7081-7095

2008

Volltextzugriff (PDF)

The Hypoxia-Associated Factor Switches Cells from HIF-1α- to HIF-2α-Dependent Signaling Promoting Stem Cell Characteristics, Aggressive Tumor Growth and Invasion

Cancer research (Chicago, Ill.), 2011-06, Vol.71 (11), p.4015-4027

2011

Volltextzugriff (PDF)

HAF: The new player in oxygen-independent HIF-1α degradation

Cell cycle (Georgetown, Tex.), 2009-05, Vol.8 (9), p.1359-1366

2009

Volltextzugriff (PDF)

Inhibiting the Hypoxia Response for Cancer Therapy: The New Kid on the Block

Clinical cancer research, 2009-10, Vol.15 (19), p.5945-5946

2009

Volltextzugriff (PDF)

HIF-1 regulation: not so easy come, easy go

Trends in biochemical sciences (Amsterdam. Regular ed.), 2008-11, Vol.33 (11), p.526-534

2008

Volltextzugriff (PDF)

EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis

Molecular cell, 2012-12, Vol.48 (5), p.771-784

2012

Volltextzugriff (PDF)

Passing the baton: the HIF switch

Trends in biochemical sciences (Amsterdam. Regular ed.), 2012-09, Vol.37 (9), p.364-372

2012

Volltextzugriff (PDF)

Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma

Cancer research (Chicago, Ill.), 2015-01, Vol.75 (2), p.316-329

2015

Volltextzugriff (PDF)

The identification of a novel orally available ferroptosis inducer for the treatment of clear cell renal carcinoma

The oncologist (Dayton, Ohio), 2023-08, Vol.28 (Supplement_1), p.S10-S10

Koh, Mei Yee

2023

Volltextzugriff (PDF)

Predicting IHC staining classes of NF1 using features in the hematoxylin channel

Journal of pathology informatics, 2023-01, Vol.14, p.100196-100196, Article 100196

2023

Volltextzugriff (PDF)

Seeing the forest for the trees—single-cell atlases link CD8+ T cells and macrophages to disease progression and treatment response in kidney cancer

Cancer cell, 2021-05, Vol.39 (5), p.594-596

2021

Volltextzugriff (PDF)

Revisiting the HIF switch in the tumor and its immune microenvironment

Trends in Cancer, 2022-01, Vol.8 (1), p.28-42

2022

Volltextzugriff (PDF)

Abstract IA007: A novel strategy to trigger ferroptosis in kidney cancer

Cancer research (Chicago, Ill.), 2023-08, Vol.83 (16_Supplement), p.IA007-IA007

Koh, Mei Yee

2023

Volltextzugriff (PDF)

Expression of Kinase-defective Mutants of c-Src in Human Metastatic Colon Cancer Cells Decreases Bcl-xL and Increases Oxaliplatin- and Fas-induced Apoptosis

The Journal of biological chemistry, 2004-10, Vol.279 (44), p.46113-46121

2004

Volltextzugriff (PDF)

Hypoxia-Associated Factor (HAF) Mediates Neurofibromin Ubiquitination and Degradation Leading to Ras-ERK Pathway Activation in Hypoxia

Molecular cancer research, 2019-05, Vol.17 (5), p.1220-1232

2019

Volltextzugriff (PDF)

ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma

Oncogene, 2022-10, Vol.41 (42), p.4709-4723

2022

Volltextzugriff (PDF)

Association of serum iron and response to immune checkpoint inhibitors (ICIs) in metastatic clear cell renal cell carcinoma (mccRCC)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.723-723

2020

Volltextzugriff (PDF)

Absence of HIF1A Leads to Glycogen Accumulation and an Inflammatory Response That Enables Pancreatic Tumor Growth

Cancer research (Chicago, Ill.), 2019-11, Vol.79 (22), p.5839-5848

2019

Volltextzugriff (PDF)

Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14), p.4259-4269

2016

Volltextzugriff (PDF)

Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer

Clinical cancer research, 2020-09, Vol.26 (18), p.4970-4982

2020

Volltextzugriff (PDF)

Abstract 2096: A novel, orally available ferroptosis inducer targeting Fe-S assembly with significant in vivo anti-tumor efficacy

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.2096-2096

2024

Volltextzugriff (PDF)

A new HIF‐1α/RANTES‐driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice

Hepatology (Baltimore, Md.), 2016-05, Vol.63 (5), p.1576-1591

2016

Volltextzugriff (PDF)

EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis

Molecular cell, 2018-01, Vol.69 (2), p.347-347

2018

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(81)

Publikationsform

Sprache

Englisch
(91)

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Humans
(42)
Life Sciences & Biomedicine
(42)
Female
(17)
Male
(16)
Oncology
(16)
Animals
(12)
Singapore
(11)
Adult
(10)
Cell Line, Tumor
(10)
Mice
(9)
Aged
(8)
Hypoxia-Inducible Factor 1, Alpha Subunit - Metabolism
(8)
Middle Aged
(8)
Cell Biology
(7)
Basic Helix-Loop-Helix Transcription Factors - Metabolism
(6)
Biochemistry & Molecular Biology
(6)
Hypoxia
(6)
Infant
(6)
Medicine
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hypoxia-Associated Factor, a Novel E3-Ubiquitin Ligase, Binds and Ubiquitinates Hypoxia-Inducible Factor 1α, Leading to Its Oxygen-Independent Degradation

The Hypoxia-Associated Factor Switches Cells from HIF-1α- to HIF-2α-Dependent Signaling Promoting Stem Cell Characteristics, Aggressive Tumor Growth and Invasion

HAF: The new player in oxygen-independent HIF-1α degradation

Inhibiting the Hypoxia Response for Cancer Therapy: The New Kid on the Block

HIF-1 regulation: not so easy come, easy go

EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis

Passing the baton: the HIF switch

Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma

The identification of a novel orally available ferroptosis inducer for the treatment of clear cell renal carcinoma

Predicting IHC staining classes of NF1 using features in the hematoxylin channel

Seeing the forest for the trees—single-cell atlases link CD8+ T cells and macrophages to disease progression and treatment response in kidney cancer

Revisiting the HIF switch in the tumor and its immune microenvironment

Abstract IA007: A novel strategy to trigger ferroptosis in kidney cancer

Expression of Kinase-defective Mutants of c-Src in Human Metastatic Colon Cancer Cells Decreases Bcl-xL and Increases Oxaliplatin- and Fas-induced Apoptosis

Hypoxia-Associated Factor (HAF) Mediates Neurofibromin Ubiquitination and Degradation Leading to Ras-ERK Pathway Activation in Hypoxia

ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma

Association of serum iron and response to immune checkpoint inhibitors (ICIs) in metastatic clear cell renal cell carcinoma (mccRCC)

Absence of HIF1A Leads to Glycogen Accumulation and an Inflammatory Response That Enables Pancreatic Tumor Growth

Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target

Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer

Abstract 2096: A novel, orally available ferroptosis inducer targeting Fe-S assembly with significant in vivo anti-tumor efficacy

HAF prevents hepatocyte apoptosis and progression to MASH and hepatocellular carcinoma through transcriptional regulation of the NF-κB pathway

A new HIF‐1α/RANTES‐driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice

Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma

EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis

Suchergebnisse filtern